466 related articles for article (PubMed ID: 19517477)
21. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
[TBL] [Abstract][Full Text] [Related]
22. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer.
Moghaddam Y; Falzon M; Fulford L; Williams NR; Keshtgar MR
Br J Surg; 2010 Nov; 97(11):1646-52. PubMed ID: 20641049
[TBL] [Abstract][Full Text] [Related]
25. [Models to predict non sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node].
Coutant C; Rouzier R; Olivier C; Bezu C; Marpeau O; Delpech Y; Uzan S; Daraï E
Gynecol Obstet Fertil; 2009 Feb; 37(2):160-6. PubMed ID: 19119050
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
[TBL] [Abstract][Full Text] [Related]
27. Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients.
Chen K; Zhu L; Jia W; Rao N; Fan M; Huang H; Shan Q; Han J; Song E; Zeng Y; Su F
Cancer Sci; 2012 Feb; 103(2):274-81. PubMed ID: 22054165
[TBL] [Abstract][Full Text] [Related]
28. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
Saidi RF; Dudrick PS; Remine SG; Mittal VK
Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
[TBL] [Abstract][Full Text] [Related]
29. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
[TBL] [Abstract][Full Text] [Related]
30. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
31. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
32. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node.
Perhavec A; Perme MP; Hocevar M; Besić N; Zgajnar J
Breast Cancer Res Treat; 2010 Jan; 119(2):357-66. PubMed ID: 19787449
[TBL] [Abstract][Full Text] [Related]
33. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer.
Ponzone R; Maggiorotto F; Mariani L; Jacomuzzi ME; Magistris A; Mininanni P; Biglia N; Sismondi P
Am J Surg; 2007 Jun; 193(6):686-92. PubMed ID: 17512277
[TBL] [Abstract][Full Text] [Related]
34. Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement.
Hidar S; Harrabi I; Benregaya L; Fatnassi R; Khelifi A; Benabdelkader A; Trabelsi A; Bouaouina N; Ben Ahmed S; Bibi M; Khaïri H
Breast; 2011 Feb; 20(1):26-30. PubMed ID: 20729084
[TBL] [Abstract][Full Text] [Related]
35. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
[TBL] [Abstract][Full Text] [Related]
36. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity.
Soni NK; Carmalt HL; Gillett DJ; Spillane AJ
Eur J Surg Oncol; 2005 Nov; 31(9):958-64. PubMed ID: 15979270
[TBL] [Abstract][Full Text] [Related]
38. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
Kohrt HE; Olshen RA; Bermas HR; Goodson WH; Wood DJ; Henry S; Rouse RV; Bailey L; Philben VJ; Dirbas FM; Dunn JJ; Johnson DL; Wapnir IL; Carlson RW; Stockdale FE; Hansen NM; Jeffrey SS;
BMC Cancer; 2008 Mar; 8():66. PubMed ID: 18315887
[TBL] [Abstract][Full Text] [Related]
39. Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms.
Gruber I; Henzel M; Schönfisch B; Stäbler A; Taran FA; Hahn M; Röhm C; Helms G; Oberlechner E; Wiesinger B; Nikolaou K; LA Fougère C; Wallwiener D; Hartkopf A; Krawczyk N; Fehm T; Brucker S
Anticancer Res; 2018 Jul; 38(7):4047-4056. PubMed ID: 29970530
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.
van la Parra RF; Francissen CM; Peer PG; Ernst MF; de Roos WK; Van Zee KJ; Bosscha K
Eur J Cancer; 2013 Feb; 49(3):564-71. PubMed ID: 22975214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
